XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES (Details Narrative)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Feb. 09, 2025
shares
Jan. 07, 2025
shares
Jan. 06, 2025
shares
Jul. 01, 2024
USD ($)
Jan. 26, 2024
USD ($)
shares
Oct. 06, 2022
USD ($)
Oct. 03, 2022
Mar. 31, 2025
USD ($)
Jan. 31, 2025
shares
Jun. 30, 2012
Mar. 31, 2025
USD ($)
shares
Mar. 31, 2024
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
Dec. 31, 2024
ILS (₪)
Dec. 31, 2023
ILS (₪)
Dec. 11, 2022
USD ($)
Dec. 11, 2022
ILS (₪)
Jun. 10, 2021
USD ($)
Loss Contingencies [Line Items]                                      
Net sales royalty percenatge                     3.00%                
Gross proceeds from cash fee percentage             7.00%                        
Gross proceeds from management fee percentage             1.00%                        
Stock issued during period, value, new issues                     $ 25,917 [1] $ 2,397 [2]              
Litigation settlement amount         $ 2,154                            
Liabilities current               $ 1,893     1,893   $ 2,460            
Assets current               30,656     30,656   $ 5,819            
Settlement amount recovery                           $ 1,100          
Legal expense                           235          
Non operating loss on legal settlement                           1,111          
Proceeds from Legal Settlements               316                      
CEO, Executives [Member]                                      
Loss Contingencies [Line Items]                                      
Accrued bonuses               176     176                
Certain Employees [Member]                                      
Loss Contingencies [Line Items]                                      
Accrued bonuses               176     176                
Device [Member]                                      
Loss Contingencies [Line Items]                                      
Royalties percentage           3.00%                          
Integrated Product [Member]                                      
Loss Contingencies [Line Items]                                      
Royalties percentage           1.50%                          
Common Stock [Member]                                      
Loss Contingencies [Line Items]                                      
Stock issued during period, value, new issues                     $ 139 [1] $ 17 [2]              
Number of share issued | shares                     13,891,840 [1] 1,685,682 [2]              
At-the-Market Offering Agreement [Member] | Common Stock [Member]                                      
Loss Contingencies [Line Items]                                      
Aggregate offering       $ 4,820                              
Percentage of placement fee       3.00%                              
Number of share issued | shares                 842,606       3,433,880            
Securities Purchase Agreement [Member]                                      
Loss Contingencies [Line Items]                                      
Purchase price of plaintiffs                     $ 6,750                
Securities Purchase Agreement [Member] | Common Stock [Member]                                      
Loss Contingencies [Line Items]                                      
Number of share issued | shares 6,103,289 3,788,550 4,000,001                                
Litigation Settlement [Member]                                      
Loss Contingencies [Line Items]                                      
Payment for litigation settlement         $ 1,100             $ 1,100              
Restricted common shares issued for legal settlement | shares         1,005,965                            
Liabilities current                           2,211          
Assets current                           1,335          
Insurance recovery amount                       $ 1,335              
Litigation Settlement [Member] | Common Stock [Member]                                      
Loss Contingencies [Line Items]                                      
Number of share issued | shares                       1,005,965              
Israeli Innovation Authority [Member]                                      
Loss Contingencies [Line Items]                                      
Grants receivable                         $ 378 378     $ 83 ₪ 300,000  
Additional grant receivable                         $ 447 $ 447 ₪ 1,620,000 ₪ 1,620,000      
Israeli Innovation Authority [Member] | Minimum [Member]                                      
Loss Contingencies [Line Items]                                      
Net sales royalty percenatge                     3.00%                
Israeli Innovation Authority [Member] | Maximum [Member]                                      
Loss Contingencies [Line Items]                                      
Net sales royalty percenatge                     5.00%                
Israeli Innovation Authority [Member] | CardioSert Ltd [Member]                                      
Loss Contingencies [Line Items]                                      
Repayment of government grants           $ 925                          
Ministry of Economy [Member]                                      
Loss Contingencies [Line Items]                                      
Grants receivable               $ 50     $ 50                
Technion Research and Development Foundation Limited [Member] | Minimum [Member]                                      
Loss Contingencies [Line Items]                                      
Net sales royalty percenatge                   1.50%                  
Technion Research and Development Foundation Limited [Member] | Maximum [Member]                                      
Loss Contingencies [Line Items]                                      
Net sales royalty percenatge                   3.00%                  
H.C. Wainwright & Co. LLC [Member]                                      
Loss Contingencies [Line Items]                                      
Warrant issued, descriptions             The Company has also agreed to issue to Wainwright or its designees preferred investment options upon the closing of such offerings, equal to five (5.0%) percent of the aggregate number of such shares of common stock in such offerings, including upon exercise for cash of any warrants issued to investors in such offering. See also Note 4B below                        
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                                      
Loss Contingencies [Line Items]                                      
Offering costs                                     $ 10,000
Stock issued during period, value, new issues           $ 8,000                          
2013 Through March 31, 2025 [Member] | Israeli Innovation Authority [Member]                                      
Loss Contingencies [Line Items]                                      
Revenue grants received                     $ 1,878                
[1] Net of issuance costs in the amount of $2,683, of which $10 had not been paid as of March 31, 2025.
[2] Net of issuance costs in the amount of $333.